BG
QGENF

Bellevue Group’s QIAGEN NV QGENF Stock Holding History

Bellevue Group’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-79,444
Closed -$2.3M – 143
2017
Q1 		$2.3M Sell
79,444
-12,056
-13% -$349K 0.31% 75
2016
Q4 		$2.56M Hold
91,500
– – 0.53% 51
2016
Q3 		$2.51M Hold
91,500
– – 0.45% 61
2016
Q2 		$2M Hold
91,500
– – 0.38% 72
2016
Q1 		$2.04M Buy
+91,500
New +$2.04M 0.37% 77

Other funds holding QGENF

PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Bellevue Group's QGENF Position: Q2 2017 in Review

Bellevue Group sold out of QIAGEN NV (QGENF) in Q2 2017, closing a stake of 79,444 shares — an estimated $2.3M sold.

Bellevue Group first reported a position in QGENF in Q1 2016 and held it in 5 quarters. The position peaked at $2.56M in Q4 2016. 4 funds tracked by Wall St. Rank hold QGENF as of Q2 2017.

  • Bellevue Group reported no remaining QIAGEN NV position as of Q2 2017 after selling out during the quarter.
  • Bellevue Group sold 79,444 QIAGEN NV shares in Q2 2017, an estimated $2.3M.
  • Bellevue Group first reported a position in QIAGEN NV in Q1 2016 and held it in 5 quarters.
  • Bellevue Group's QIAGEN NV position peaked at $2.56M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2017.

Based on Bellevue Group's 13F filing for Q2 2017, filed 14 Aug 2017.